Other Charges, Net

12 Months Ended

Dec. 31, 2017

Other Charges, Net

Other Charges, Net

Note 17—Other Charges, Net

        The components of other charges, net for the years ended December 31, 2017, 2016 and 2015, were as follows in millions):

	2017		2016		2015
Acquisition-related expenses (income), net	$	4.5	$	9.0	$	(7.2	)
Professional fees incurred in connection with investigation matters		0.2		—		0.4
Pension settlement charge		—		—		10.2
Information technology transformation costs		4.2		6.2		8.9
Restructuring charges		10.6		9.8		8.1
Long-lived asset impairments		0.2		0.8		4.6
Other charges, net	$	19.7	$	25.8	$	25.0

Restructuring Initiatives

2016

        The Company commenced a restructuring initiative in 2016 to address lower demand in the Bruker CALID and Bruker Nano Groups as a result of delays in European academic funding and ongoing weakness in several of the industrial end market segments that affect the Bruker Nano Group. This initiative was intended to improve the Bruker CALID and Bruker Nano Group operating results in response to these market conditions. Restructuring actions will result in a reduction of approximately 125 employees within the Bruker CALID and Bruker Nano Groups.

        The following is a summary of the restructuring expenses related to this initiative which are recorded in the accompanying consolidated statements of income and comprehensive income for the years ended December 31, 2017 and 2016:

	2017						2016
	Severance and Exit Costs		Inventory Writedown and Asset Impairment		Total		Severance and Exit Costs		Inventory Writedown and Asset Impairment		Total
Cost of revenues	$	3.5	$	0.5	$	4.0	$	4.4	$	2.4	$	6.8
Other charges, net		3.0		—		3.0		3.4		0.2		3.6
	$	6.5	$	0.5	$	7.0	$	7.8	$	2.6	$	10.4

2015

        The Company commenced a restructuring initiative in the second quarter of 2015 within the Bruker BioSpin Group, which was developed as a result of a revenue decline that occurred during the second half of 2014 and continued during the first half of 2015. This initiative was intended to improve Bruker BioSpin Group's operating results. Restructuring actions resulted in a reduction of employee headcount within the Bruker BioSpin Group of approximately 9% and the closure and consolidation of a Bruker BioSpin Group manufacturing facility.

        The following is a summary of the restructuring expenses related to this initiative which are recorded in the accompanying consolidated statements of income and comprehensive income for years ended December 31, 2017, 2016 and 2015:

	2017								2016						2015
	Severance and Exit Costs			Inventory Writedown and Asset Impairment		Total			Severance and Exit Costs		Inventory Writedown and Asset Impairment		Total		Severance and Exit Costs		Inventory Writedown and Asset Impairment		Total
Cost of revenues	$	(2.7	)	$	—	$	(2.7	)	$	2.2	$	—	$	2.2	$	10.2	$	2.1	$	12.3
Other charges, net		—			—		—			1.1		—		1.1		1.8		2.1		3.9
	$	(2.7	)	$	—	$	(2.7	)	$	3.3	$	—	$	3.3	$	12.0	$	4.2	$	16.2

        As of December 31, 2017, expenses incurred under this restructuring initiative were substantially complete.

        Restructuring charges for the years ended December 31, 2017, 2016 and 2015 included charges for various other programs which were recorded in the accompanying consolidated statements of income and comprehensive income as follows:

	2017		2016		2015
Cost of revenues	$	4.3	$	2.0	$	8.9
Other charges, net		7.6		5.1		4.2
	$	11.9	$	7.1	$	13.1

        The following table sets forth the changes in the restructuring reserves for the years ended December 31, 2017, 2016 and 2015 (in millions):

	Total			Severance			Exit Costs			Provisions for Excess Inventory
Balance at December 31, 2014	$	16.1		$	7.1		$	1.3		$	7.7
Restructuring charges		29.3			15.9			6.4			7.0
Cash payments		(18.0	)		(11.9	)		(5.1	)		(1.0	)
Non-cash adjustments		(2.9	)		(0.2	)		(0.2	)		(2.5	)
Foreign currency impact		(1.4	)		(0.6	)		—			(0.8	)
Balance at December 31, 2015	$	23.1		$	10.3		$	2.4		$	10.4
Restructuring charges		20.8			10.6			7.2			3.0
Cash payments		(22.1	)		(15.6	)		(5.6	)		(0.9	)
Non-cash adjustments		(5.4	)		(0.4	)		(0.3	)		(4.7	)
Foreign currency impact		(0.2	)		—			—			(0.2	)
Balance at December 31, 2016	$	16.2		$	4.9		$	3.7		$	7.6
Restructuring charges		16.2			7.7			6.2			2.3
Cash payments		(17.1	)		(10.1	)		(6.8	)		(0.2	)
Non-cash adjustments		(5.5	)		(0.7	)		(1.0	)		(3.8	)
Foreign currency impact		1.0			0.2			—			0.8
Balance at December 31, 2017	$	10.8		$	2.0		$	2.1		$	6.7

        Restructuring charges by segment as of and for the years ended December 31, are as follows (in millions):

	2017		2016		2015
BSI	$	14.1	$	20.8	$	28.4
BEST		2.1		—		0.9
	$	16.2	$	20.8	$	29.3